Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Hefeng Pharmaceutical is a prominent pharmaceutical manufacturing company based in China and a core subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company specializes in the production of high-quality finished dosage forms, particularly focusing on small molecule therapeutics for cardiovascular, endocrine, and anti-inflammatory applications. With a history dating back to the mid-20th century, Hefeng has established itself as a reliable provider of essential medicines in the Chinese market. Its facilities are equipped with modern GMP-certified production lines for various formulations including tablets, capsules, and injections. As part of the SPH group, it benefits from extensive distribution networks and robust R&D support.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Hefeng Pharmaceutical.